Examining the Impact of High-protein Oral Supplement on Protein Status of Adults on Peritoneal Dialysis

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

September 1, 2024

Study Completion Date

September 1, 2024

Conditions
Renal FailureProtein-Energy Malnutrition
Interventions
DIETARY_SUPPLEMENT

Whey protein supplement

A monthly supply of 35 g of whey protein isolate will be provided to participants in individual sachet packets with instructions of preparation. Every month, participants will come to the center to provide the standard monthly blood sample. At this time, the PI will have participants complete the quality-of-life instrument, ask if there have been any changes in their dietary habits, and collect weights for up to 6-months. Additionally, participants will indicate if they had consumed the protein daily and/or bring back their empty/full satchel packets. As this is a feasibility trial, it is necessary to determine the compliancy of consuming protein daily and the amount. Furthermore, understanding how protein markers may be affected by consumption of the protein daily vs less frequently throughout the week is important to establish improved recommendations for consumption of protein supplements.

Trial Locations (2)

32606

University of Florida, Gainesville

32611

UF Health Dialysis Center, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER

NCT06154161 - Examining the Impact of High-protein Oral Supplement on Protein Status of Adults on Peritoneal Dialysis | Biotech Hunter | Biotech Hunter